Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VIVO Cannabis Inc. VVCIF

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical... see more

OTCQB:VVCIF - Post Discussion

VIVO Cannabis Inc. > This is what you get with FAT lazy exec's !! Called IT !!!!
View:
Post by 1hot-techwoman on May 18, 2021 7:27am

This is what you get with FAT lazy exec's !! Called IT !!!!

Put the company up for Sale !! Pathetic!!

VIVO Cannabis Announces First Quarter 2021 Results

Monday, May 17, 2021, 6:20 PM ET
 

 -- Net revenue of $5.5 million -- a decrease of 11% over Q4 2020 -- Vanluven facility received EU-GMP certification allowing VIVO to export cannabis products for sale in Europe and Beacon Medical Germany GmbH received an import license to allow imports of medical cannabis -- Released brick hash as part of VIVO's Cannabis 2.0 product lineup and expect to release a new line of topicals in Q2 2021, VIVO's 9th and 10th product formats, respectively -- Closed an $8 million equity offering in February 2021, including the full exercise of the over-allotment option 
Comment by Vikingstock on May 18, 2021 7:52am
Results topline % chg vs prior qtr and prior qtr pY are in line with what others have reported in the Covid era. Got to get German, Australian sales going, work to maintain share in Canada.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities